Return
Company Page
StandardX
Founders
StandardX is a UK-based deep tech company building the world's first accelerator-based isotope refinery, designed to produce a broad portfolio of rare isotopes at commercial scale. Its proprietary platform addresses a fragmented and reactor-dependent global supply chain, targeting critical applications in cancer diagnostics, targeted radiotherapy, and fusion energy fuel (tritium). The company has signed agreements with fusion developers and plans to begin pilot medical isotope production in 2027, scaling to full industrial output by 2029.
Company Founded in 2025
Climate / Social Tech
